Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO.

Clearside Biomedical today announced that the ODYSSEY study of its drug-device combination achieved its primary and secondary ...

BD (NYSE:BDX) announced today that it entered into a collaboration with ten23 health to develop a new way to track ...

Trinity Biotech today announced that it completed the first pre-pivotal clinical trial in Europe for its next-generation CGM ...

Medinol today announced the successful first-in-human implantation of its ChampioNIR drug-eluting peripheral stent.

The National Institutes of Health (NIH) launched a nationwide consortium to address the rise in youth diagnosed with type 2 ...